Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc G Caron

Showing results (221-230 of 232) with videos related to

Pageof 24
Sort By:
Biological Psychiatry|June 19, 2012
Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeuticsFlorent G Revel, Jean-Luc Moreau, Raul R Gainetdinov, et al.
Molecular Cancer Research : MCR|June 16, 2021
HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic PhaseJoshua D Ginzel, Chaitanya R Acharya, Veronica Lubkov, et al.
Cell|May 20, 2025
Arrestin-biased allosteric modulator of neurotensin receptor 1 alleviates acute and chronic painRan Guo, Ouyang Chen, Yang Zhou, et al.
Nature Communications|February 2, 2017
β-arrestin-2 is an essential regulator of pancreatic β-cell function under physiological and pathophysiological conditionsLu Zhu, Joana Almaça, Prasanna K Dadi, et al.
Molecular and Cellular Biology|July 29, 2009
The vesicular acetylcholine transporter is required for neuromuscular development and functionBraulio M de Castro, Xavier De Jaeger, Cristina Martins-Silva, et al.
Eneuro|January 13, 2023
Measuring Nonapoptotic Caspase Activity with a Transgenic Reporter in MiceP J Nicholls, Thomas F Pack, Nikhil M Urs, et al.
ACS Chemical Neuroscience|June 28, 2012
Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement StrategyKevin J Frankowski, Michael P Hedrick, Palak Gosalia, et al.
Annals of the New York Academy of Sciences|October 29, 2011
Advancing drug discovery for schizophreniaStephen R Marder, Bryan Roth, Patrick F Sullivan, et al.
The Journal of Clinical Investigation|November 9, 2020
Cholinergic dysfunction in the dorsal striatum promotes habit formation and maladaptive eatingMathieu Favier, Helena Janickova, Damian Justo, et al.
ACS Medicinal Chemistry Letters|March 11, 2014
Discovery of ML314, a Brain Penetrant Non-Peptidic β-Arrestin Biased Agonist of the Neurotensin NTR1 ReceptorSatyamaheshwar Peddibhotla, Michael P Hedrick, Paul Hershberger, et al.
Pageof 24

Showing results (221-230 of 232) with videos related to

Sort By:
Pageof 24
Biological Psychiatry|June 19, 2012
Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeuticsFlorent G Revel, Jean-Luc Moreau, Raul R Gainetdinov, et al.
Molecular Cancer Research : MCR|June 16, 2021
HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic PhaseJoshua D Ginzel, Chaitanya R Acharya, Veronica Lubkov, et al.
Cell|May 20, 2025
Arrestin-biased allosteric modulator of neurotensin receptor 1 alleviates acute and chronic painRan Guo, Ouyang Chen, Yang Zhou, et al.
Nature Communications|February 2, 2017
β-arrestin-2 is an essential regulator of pancreatic β-cell function under physiological and pathophysiological conditionsLu Zhu, Joana Almaça, Prasanna K Dadi, et al.
Molecular and Cellular Biology|July 29, 2009
The vesicular acetylcholine transporter is required for neuromuscular development and functionBraulio M de Castro, Xavier De Jaeger, Cristina Martins-Silva, et al.
Eneuro|January 13, 2023
Measuring Nonapoptotic Caspase Activity with a Transgenic Reporter in MiceP J Nicholls, Thomas F Pack, Nikhil M Urs, et al.
ACS Chemical Neuroscience|June 28, 2012
Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement StrategyKevin J Frankowski, Michael P Hedrick, Palak Gosalia, et al.
Annals of the New York Academy of Sciences|October 29, 2011
Advancing drug discovery for schizophreniaStephen R Marder, Bryan Roth, Patrick F Sullivan, et al.
The Journal of Clinical Investigation|November 9, 2020
Cholinergic dysfunction in the dorsal striatum promotes habit formation and maladaptive eatingMathieu Favier, Helena Janickova, Damian Justo, et al.
ACS Medicinal Chemistry Letters|March 11, 2014
Discovery of ML314, a Brain Penetrant Non-Peptidic β-Arrestin Biased Agonist of the Neurotensin NTR1 ReceptorSatyamaheshwar Peddibhotla, Michael P Hedrick, Paul Hershberger, et al.
Pageof 24